[go: up one dir, main page]

PH12012501203A1 - Combination of theobromine with a decongestant and its use for the treatment of cough - Google Patents

Combination of theobromine with a decongestant and its use for the treatment of cough

Info

Publication number
PH12012501203A1
PH12012501203A1 PH1/2012/501203A PH12012501203A PH12012501203A1 PH 12012501203 A1 PH12012501203 A1 PH 12012501203A1 PH 12012501203 A PH12012501203 A PH 12012501203A PH 12012501203 A1 PH12012501203 A1 PH 12012501203A1
Authority
PH
Philippines
Prior art keywords
decongestant
cough
theobromine
treatment
combination
Prior art date
Application number
PH1/2012/501203A
Inventor
Robin Mark Bannister
John Brew
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of PH12012501203A1 publication Critical patent/PH12012501203A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

An agent comprises theobromine and a decongestant, as a combined preparation for simultaneous, sequential or separate use in therapy, particularly in the therapy of cough.
PH1/2012/501203A 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough PH12012501203A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0921805.8A GB0921805D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy
PCT/GB2010/052085 WO2011073646A1 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough

Publications (1)

Publication Number Publication Date
PH12012501203A1 true PH12012501203A1 (en) 2012-11-05

Family

ID=41667045

Family Applications (1)

Application Number Title Priority Date Filing Date
PH1/2012/501203A PH12012501203A1 (en) 2009-12-14 2010-12-14 Combination of theobromine with a decongestant and its use for the treatment of cough

Country Status (19)

Country Link
EP (1) EP2512464A1 (en)
JP (2) JP2013513651A (en)
CN (2) CN105816462A (en)
AU (1) AU2010332494B2 (en)
BR (1) BR112012014161A2 (en)
CA (1) CA2784214C (en)
CO (1) CO6541630A2 (en)
EC (1) ECSP12012132A (en)
GB (1) GB0921805D0 (en)
IL (1) IL220383A (en)
MX (1) MX343222B (en)
NZ (1) NZ600243A (en)
PE (1) PE20121537A1 (en)
PH (1) PH12012501203A1 (en)
RU (1) RU2564904C2 (en)
SG (2) SG10201408377QA (en)
UA (1) UA105944C2 (en)
WO (1) WO2011073646A1 (en)
ZA (1) ZA201204293B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995007103A1 (en) * 1993-09-07 1995-03-16 The Procter & Gamble Company Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
HUP9700654A2 (en) * 1997-03-26 1999-09-28 Dezső Korbonits Antitussive compositions containing theobromine
US6417206B1 (en) * 2001-01-26 2002-07-09 Medpointe Healthcare Inc. Antitussive/antihist aminic/decongestant compositions
JP2002308761A (en) * 2001-04-09 2002-10-23 Taisho Pharmaceut Co Ltd Cold cough medicine
JP2003128549A (en) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd Composition applicable to mucous membrane
JP4377564B2 (en) * 2002-05-02 2009-12-02 ロート製薬株式会社 Composition for internal use
RU2311919C2 (en) * 2002-12-30 2007-12-10 Каунсел Оф Сайнтифик Энд Индастриал Рисерч Development of anti-coughing and throat softening herbal composition
US20040202677A1 (en) * 2003-04-10 2004-10-14 Hopkins Kevin J. Method of enhanced regional body fat reduction
US20060153926A1 (en) * 2005-01-10 2006-07-13 Bascom Charles C Compositions, products and methods for controlling weight in a mammal
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
CN100518775C (en) * 2007-03-16 2009-07-29 邓丽菊 Medicine composition for treating cough and asthma and preparation thereof

Also Published As

Publication number Publication date
IL220383A (en) 2017-01-31
RU2564904C2 (en) 2015-10-10
AU2010332494A1 (en) 2012-06-14
SG181686A1 (en) 2012-07-30
CA2784214A1 (en) 2011-06-23
CO6541630A2 (en) 2012-10-16
UA105944C2 (en) 2014-07-10
ZA201204293B (en) 2013-02-27
NZ600243A (en) 2013-07-26
IL220383A0 (en) 2012-08-30
GB0921805D0 (en) 2010-01-27
SG10201408377QA (en) 2015-02-27
ECSP12012132A (en) 2012-09-28
BR112012014161A2 (en) 2016-05-17
CA2784214C (en) 2018-01-09
MX343222B (en) 2016-10-28
CN105816462A (en) 2016-08-03
PE20121537A1 (en) 2012-12-21
WO2011073646A1 (en) 2011-06-23
JP2013513651A (en) 2013-04-22
RU2012129839A (en) 2014-01-27
EP2512464A1 (en) 2012-10-24
CN102740843A (en) 2012-10-17
JP2016040279A (en) 2016-03-24
MX2012006625A (en) 2012-10-05
AU2010332494B2 (en) 2015-01-15

Similar Documents

Publication Publication Date Title
AU319701S (en) Therapy unit
PH12012501200A1 (en) Therapeutic combinations of theobromine and an antihistamine
PH12013500392A1 (en) Theobromine in combination with an expectorant or a mucolytic for use in therapy
PH12012501203A1 (en) Combination of theobromine with a decongestant and its use for the treatment of cough
AU321640S (en) Therapy apparatus
PH12012501369A1 (en) Drug combination with theobromine and its use in therapy
PH12012500955A1 (en) Drug combination with theobromine and its use in therapy
GB0908875D0 (en) Depsipeptides and their therapeutic use
GB0910375D0 (en) Drug composition and its use in therapy
WO2010150098A3 (en) Use of quingolide in the treatment of endometriosis, pain and cancer
GB0908873D0 (en) Depsipeptides and their therapeutic use
UA44395U (en) Use of tiocetam as a diuretic drug with mild emictory action in a complex treatment
UA34815U (en) Method for correcting cytokine state in patients with acute tonsillitis
UA57852U (en) Method for treating recurrent forms of allergodermatosis in patients with secondary immunodeficiency
GB0920267D0 (en) Drug combination and its use in therapy
UA29192U (en) Adsorbing preparation with combined therapeutic action
ECSP12011969A (en) THERAPEUTIC COMBINATIONS OF THEOBROMINE AND AN ANTIHISTAMINE
GB0918727D0 (en) Drug composition and its use in therapy
GB0921804D0 (en) Drug composition and its use in therapy
GB0909354D0 (en) Drug composition and its use in therapy
GB0919890D0 (en) Drug composition and its use in therapy
GB0918728D0 (en) Drug composition and its use in therapy
GB0909352D0 (en) Drug composition and its use in therapy
UA34825U (en) Method for immunocorrection of patients with chronic periodontitis in setting of secondary immunodeficiency
GB0809324D0 (en) Depsipeptides and their therapeutic use